TheProfitWatch

ANRO - Alto Neuroscience Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.51 0.51 (9.26%) --- --- --- -0.07 (-1.36%) 0.55 (9.84%) -0.1 (-1.63%) -0.1 (-1.63%)

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.56
Diluted EPS:
-0.56
Basic P/E:
-10.75
Diluted P/E:
-10.75
RSI(14) 1m:
0.0
VWAP:
6.02
RVol:
0.096

Events

Period Kind Movement Occurred At
1m Price increase 1m 5.68 +0.09 (+1.61%) Oct 15 09:30

Related News